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Fine particles (particles < 2.5 µm in aerody-
namic diameter; PM2.5) have been linked to 
a variety of poor health outcomes, includ-
ing mortality and cardiorespiratory morbid-
ity (Dominici et al. 2006; Ostro et al. 2006; 
Schwartz et al. 1996). However, PM2.5 
encompasses a chemically heterogeneous mix 
of solid and liquid particles emitted from 
a variety of sources, and it is likely that the 
different chemical species within PM2.5 will 
have varying effects on specific health end 
points. Several epidemiologic studies have 
attempted to address this question, looking at 
the effects of specific fine particle species on 
mortality (Burnett et al. 2000; Franklin et al. 
2008; Laden et al. 2000; Ostro et al. 2007). 
However, studies such as those by Burnett 
et al. (1995) and Peel et al. (2005) examining 
associations between specific PM2.5 constitu-
ents and morbidity outcomes such as hospital 
admissions, particularly among children, have 
been less common. With regulatory agencies 
actively targeting PM constituents for pollu-
tion control, a greater understanding of the 
impacts of current and future control efforts 
is needed. 
Children are a demographic of special 
concern, as they represent a population at 
increased risk for air pollution–related respira-
tory conditions because of their biologic char-
acteristics (e.g., immature lungs and immune 
system, higher breathing rates) and behav-
ior (e.g., more time spent outdoors) (Miller 
et al. 2002; Schwartz 2004). Particle depo-
sition, specifically, is higher in both young 
children and asthmatics (Chalupa et al. 2000; 
Ginsberg et al. 2005), and several studies have 
observed associations between PM2.5 and 
bronchitis and asthma exacerbation in chil-
dren (Barnett et al. 2005; McConnell et al. 
2003). Thus, when designing and instituting 
pollution controls, the impacts on children 
from exposure to components of PM2.5 need 
to be documented.
Our study used speciated PM2.5 monitor-
ing data to examine the association between 
PM2.5 and its constituents with respiratory 
hospitalizations among children 0–18 years of 
age in six California counties. Our goal is to 
provide further insight into the relative toxic-
ity of fine particle constituents, which would 
generate multiple benefits. For example, such 
an analysis would identify specific agents of 
greater concern within particulate matter 
(PM), which could be more thoroughly inves-
tigated on a mechanistic level in toxicology 
studies. Second, it would help identify which 
communities may be at greater risk because 
of their specific constituent mix of PM2.5. 
Finally, it could implicate certain fine particle 
sources as posing a greater health threat based 
on the chemical profile of the fine particles 
they emit. In fact, certain constituents can be 
used as indicators of PM2.5 specific to sources 
such as gasoline and diesel exhaust, crustal 
material, and fuel combustion from stationary 
sources such as power plants, wood smoke, 
and other biomass burning. 
Data and Methods
Hospitalization data. We obtained data 
for all hospitalizations in California from 
the Office of Statewide Health Planning 
and Development, Healthcare Quality and 
Analysis Division (Sacramento, CA), for 
the period from 1 January 2000 through 31 
December 2003. Based on the International 
Classification of Diseases, 9th Revision (ICD-9) 
(World Health Organization 1975), hospi-
tal admissions for children < 19 years of age 
were classified into one or more categories: all 
respiratory disease (ICD-9 codes 460–519), 
asthma (ICD-9 code 493), acute bronchitis 
(ICD-9 code 466), and pneumonia (ICD-9 
codes 480–486). Hospital admission counts 
were then aggregated based on the child’s 
reported county of residence to yield a daily 
time-series of relevant hospitalizations for 
each county. For total respiratory admissions, 
we further stratified by ages < 5 years and 
5–18 years of age. Finally, we examined the 
same outcomes for the cool season, defined 
here as October through March. 
Pollutant and meteorologic data. 
Available PM2.5 speciation data were obtained 
for 2000–2003 from the California Air 
Resources Board (Sacramento, CA). The spe-
ciation monitors were filter-based Met One 
Speciation Air Sampling Systems (SASS) 
(Met One Instruments Inc., Grants Pass, OR) 
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Ba c k g r o u n d: Epidemiologic studies have demonstrated an association between acute exposure to 
ambient fine particles and both mortality and morbidity. Less is known about the relative impacts of 
the specific chemical constituents of particulate matter < 2.5 µm in aerodynamic diameter (PM2.5) 
on hospital admissions. 
oB j e c t i v e: This study was designed to estimate the risks of exposure to PM2.5 and several species 
on hospital admissions for respiratory diseases among children. 
da t a a n d M e t h o d s: We obtained data on daily counts of hospitalizations for children < 19 and 
< 5 years of age for total respiratory diseases and several subcategories including pneumonia, acute 
bronchitis, and asthma for six California counties from 2000 through 2003, as well as ambient con-
centrations of PM2.5 and its constituents, including elemental carbon (EC), organic carbon (OC), 
and nitrates (NO3). We used Poisson regression to estimate risks while controlling for important 
covariates. 
re s u l t s: We observed associations between several components of PM2.5 and hospitalization for 
all of the respiratory outcomes examined. For example, for total respiratory admissions for chil-
dren < 19 years of age, the interquartile range for a 3-day lag of PM2.5, EC, OC, NO3, and sulfates 
was associated with an excess risk of 4.1% [95% confidence interval (CI), 1.8–6.4], 5.4% (95% 
CI, 0.8–10.3), 3.4% (95% CI, 1.1–5.7), 3.3% (95% CI, 1.1–5.5), and 3.0% (95% CI, 0.4–5.7), 
respectively. We also observed associations for several metals. Additional associations with several of 
the species, including potassium, were observed in the cool season. 
co n c l u s i o n: Components of PM2.5 were associated with hospitalization for several childhood 
respiratory diseases including pneumonia, bronchitis, and asthma. Because exposure to components 
(e.g., EC, OC, NO3, and K) and their related sources, including diesel and gasoline exhaust, wood 
smoke, and other combustion sources, are ubiquitous in the urban environment, it likely represents 
an identifiable and preventable risk factor for hospitalization for children. 
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belonging to the Speciation Trends Network 
(STN). Counties were included if there were 
≥ 180 days of observations with PM2.5 species 
data during the study period, which limited 
the study to six California counties with a 
sufficient duration of speciated PM2.5 moni-
toring. These counties encompass approxi-
mately 8.7 million people, or roughly 25% 
of the state’s population. In Kern, Riverside, 
and Santa Clara Counties, speciation data 
from two co-located monitors were avail-
able. Fresno, Sacramento, and San Diego 
Counties each had one monitor with relevant 
data. Speciation data were generally recorded 
every 3 days. The number of available days of 
data over the 4-year period ranged from 227 
(San Diego) to 381 (Sacramento), because of 
varying monitor start dates. The components 
of PM2.5 were measured as 24-hr averages 
and included elemental carbon (EC), organic 
carbon (OC), nitrates (NO3), sulfates (SO4), 
copper (Cu), iron (Fe), potassium (K), silicon 
(Si), and zinc (Zn). These species were chosen 
because they a) include the larger components 
of PM2.5 in our study sample; b) had a signal-
to-noise ratio of ≥ 2, and c) had a majority of 
their values greater than the detection limit for 
each county monitor used. Signal-to-noise ratio 
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To adjust for the potential confounding 
between temperature and hospital admis-
sions, average daily temperature and relative 
humidity data were collected at meteorologic 
stations at each of the counties using data 
provided by the California Air Resources 
Board (unpublished data) or the California 
Irrigation Management Information System 
(wwwcimis.water.ca.gov/cimis/data.jsp). The 
daily hospital admission counts and pollu-
tion and meteorologic data were integrated 
using SAS (version 9.1; SAS Institute Inc., 
Cary, NC). 
Methods. The daily hospital admission 
counts are non-negative discrete integers that 
correspond to rare events. Therefore, our 
analysis used Poisson regression conditional 
on the explanatory variables: time, day of the 
week, temperature, relative humidity, and 
pollutant. Similar model specifications were 
used for each county and included natural 
spline smoothers for both a daily time trend 
and meteorology. The natural spline fits 
multiple parametric cubic functions evenly 
placed over the range of the variable, such 
that controlling the total number of fitting 
functions, or degrees of freedom (df), controls 
the smoothness of the resulting spline. The 
smoothing of the relationship between time 
and hospital admissions helps to control for 
the effects of seasonality and other factors that 
are time dependent. Issues and sensitivity of 
model and knot selection have been discussed 
previously (Ostro et al. 2006). 
The explanatory variables were day of the 
week, smoothed splines of daily unlagged 
average temperature and humidity (each with 
3 df), and a smoothing spline of time with 
4 df per calendar year. The lags and degrees 
of freedom for meteorologic variables were 
chosen based on their effectiveness in control-
ling for weather variables and promoting best 
model fits in both this analysis and previous 
studies (Basu et al. 2008; Ostro et al. 2006). 
Similarly, 4 df were chosen for the time spline 
a priori because this number controls well 
for seasonal and secular patterns (Ostro et al. 
2006). For each county, each species was then 
examined separately in a model using sin-
gle-day lags of 0–3. Analyses looking at cool 
Table 1. Mean county daily hospital admissions per day by morbidity category and air quality and meteoro-
logic data, 2000–2003. 
  Fresno  Kern  Riverside  Sacramento  San Diego  Santa Clara
Hospitalizations admission category (age)
  Respiratory (< 19 years)  6.1  3.9  10.2  4.8  9.8  6.1
  Respiratory (< 5 years)  4.7  3.0  7.7  3.5  7.1  4.8
  Respiratory (5–18 years)  1.4  0.9  2.5  1.3  2.7  1.3
  Asthma (< 19 years)  1.7  0.8  2.4  1.3  2.8  1.4
  Pneumonia (< 19 years)  1.5  1.7  3.6  1.4  2.7  1.7
  Acute bronchitis (< 19 years)  1.9  0.8  2.6  1.2  2.2  1.7
County characteristics           
  Population (1,000s)  799  662  1,545  1,223  2,814  1,683
  Mean temperature (°F)  64.7  65.5  65.4  61.0  61.4  57.5
  Mean relative humidity (%)  56.6  57.7  58.7  68.7  74.2  68.0
  Mean PM2.5  22.4  21.4  28.8  14.8  15.6  15.0
  No. of days in analysis  373  283  279  381  227  324
Table 2. Descriptive statistics for air pollutant species in California counties, 2000–2003.
    Full-year mean  Full-year IQR  Cool season mean  Cool season IQR
  No.a  (µg/m3 )  (µg/m3 )  (µg/m3 )  (µg/m3 )
PM2.5  1,867  19.4  14.6  24.8  21.5
EC  1,867  1.0  0.8  1.4  1.2
OC  1,867  7.1  4.5  9.3  6.3
NO3  1,805  5.4  5.7  7.3  8.1
SO4  1,805  2.0  1.5  1.5  1.2
Cu  1,869  0.0077  0.0074  0.0080  0.0081
Fe  1,869  0.13  0.10  0.14  0.12
K  1,869  0.12  0.08  0.14  0.11
Si  1,869  0.18  0.15  0.15  0.13
Zn  1,869  0.012  0.010  0.018  0.014
aTotal number of days across the six counties.
Table 3. Single-day lags asssociated with respiratory admissions by cause and age. 
  Respiratory  Respiratory  Respiratory  Asthma  Pneumonia  Acute bronchitis
   (< 19 years)   (< 5 years)   (5–18 years)   (< 19 years)   (< 19 years)   (< 19 years)
Full year            
  PM2.5  1**, 3**  1*, 2*, 3**  1**, 3*     1*  1**, 3**
  EC  3**  3**     3*      
  OC  1**, 3**  1*, 3**        1**, 3*  1**, 3**
  NO3  1**, 3**  3**  1*, 3*  1*     3*
  SO4  3**  1*, 3**           3**
  Cu  2**  2**  2*     2**   
  Fe  1**, 3**  1*, 3**     0*, 1**, 3*  3**   
  K        2*         
  Si  3**  3**     1*  3*  2**
  Zn           3*  0**   
Winter           
  PM2.5  1**, 3**  1**, 2*, 3**        1*  1**, 3*
  EC  3*  3*           3*
  OC  1*, 3**  3**        1**  1**, 3**
  NO3  1**, 3**  3**  1*  1**, 3**      
  SO4  1*           0*   
  Cu  1**, 2**  1**, 2**     1**  2**  1*
  Fe  1*, 3**  1*, 3**     1*      
  K  1**, 2*, 3**  1**, 2*, 3**        1**, 3*  1**
  Si  2*  1*, 2**     1*     2**
  Zn              0**   
*Single-day lag significant at p < 0.10. **Single-day lag significant at p < 0.05. Fine particle components and hospitalization
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season (October–March) effects followed the 
same structure but included a binary indicator 
for season (warm vs. cool) and an interaction 
variable for season and pollutant. County-
specific results were later combined in a meta-
analysis, using a random-effects model to help 
account for heterogeneity between county 
estimates (DerSimonian and Laird 1986). 
In contrast to time-series studies with con-
secutive daily data, different lags in our analy-
ses will relate to different days in the time 
series of hospital admissions. For example, an 
unlagged analysis compares pollutant read-
ings with admission counts occurring on the 
pollutant sampling days. An analysis using 
1-day lags would compare those same pollut-
ant readings to admissions occurring 1 day 
after the sampling day. So although our pol-
lutant data are not available on a daily basis, 
the daily outcome data afford us the ability to 
examine different single-day lags. 
We calculated the results using R (version 
2.6.2; R Development Core Team 2006) for 
the single-county and meta-analyses. To com-
pare relative impacts of the observed concen-
trations of the species components of PM2.5, 
we present the results as the percent excess 
risk (ER) in daily hospital admissions for the 
interquartile range (IQR = 75th–25th percen-
tile) of daily exposure for each species, where 
ER per IQR = [(ebeta × IQR) – 1]  × 100 and 
beta is the combined regression coefficient 
from the meta-analysis.
Results
Table 1 provides descriptive statistics about 
the county characteristics, hospitalizations, 
PM2.5 and its components, and meteorologic 
data. As displayed in Table 1, the average 
number of daily respiratory hospital admis-
sions for children < 19 years of age ranged 
from 3.9 in Kern County to 10.2 in Riverside 
County, with children < 5 years of age gen-
erating about 75% of the admissions. Mean 
daily PM2.5 concentrations during the study 
period averaged 19 µg/m3 with a range of 15 
µg/m3 in Sacramento to 29 µg/m3 in Riverside 
County, which exceed the U.S. Environmental 
Protection Agency annual average PM2.5 stan-
dard of 15 µg/m3 in five of the six counties, 
and the California annual average standard of 
12 µg/m3 in all six counties. 
Table 2 shows the number of useable obser-
vations, mean, and IQR of each component of 
PM2.5. In this data set, PM2.5 is dominated 
by EC, OC, NO3, and SO4 which are 5%, 
36%, 28%, and 10% of the total, respectively. 
We generally found  moderate correlations (r 
< 0.5) among the species, whereas we observed 
high correlations between PM2.5 and EC, OC, 
and NO3 (0.7, 0.8, and 0.9, respectively). 
Table 3 summarizes the empirical relation-
ships between the health end points and the 
various lags of PM2.5 and its species. Many 
species were associated with total hospitaliza-
tions for respiratory disease, particularly for 
those < 5 years of age. We observed associa-
tions with multiple lags of PM2.5, OC, NO3, 
and Fe, and significant associations for EC, 
SO4, Cu, and Si. Single-day lags of 1–3 days 
were usually more important than unlagged 
values. The disease-specific results suggest that 
PM2.5 and its components were most associ-
ated with acute bronchitits and pneumonia, 
but we observed associations for asthma admis-
sions as well. Analyses of the cool season indi-
cated similar associations between the species 
and the various health end points. In addition, 
additional associations were observed between 
K and admissions for all respiratory disease as 
well as with pneumonia and bronchitis. 
Figure 1 summarizes the excess risks for 
all-year respiratory hospital admissions among 
children < 19 years of age. For ease in inter-
pretation, only single-day lags of 0 and 3 are 
presented in the figures. With collection of 
species data every third day, these lags cor-
respond to the same count day of hospital 
admissions. However, additional details on 
other lags are provided in the Supplemental 
Material (online at http://www.ehponline.
org/members/2008/11848/suppl.pdf). For a 
3-day lag, excess risks of 3–6% for the IQR 
were observed for many of the PM2.5 species, 
with the highest risks observed for PM2.5, EC, 
and Fe with respective excess risks of 4.1% 
[95% confidence interval (CI), 1.8–6.4], 
5.4% (95% CI, 0.8–10.3), and 4.7% (95% 
CI, 2.2–7.2), respectively. Excess risks of 
approximately 3% were observed for OC, 
NO3, SO4, and Si. 
Figure 2 summarizes the excess risks for 
respiratory hospital admissions during the 
cool season for those < 19 years of age. Again, 
higher effect estimates per species IQR were 
observed for PM2.5, EC, and Fe compared with 
other species, with the excess risks using the 
same 3-day lag in the cool season being 5.1% 
(95% CI, 1.6 to 8.9), 6.8% (95% CI, –0.2 to 
14.2), and 4.8% (95% CI, 1.7 to 8.0), respec-
tively. Except for SO4, other species associated 
with juvenile respiratory admissions in full-year 
analyses remained significant in cool season 
analyses, with excess risks per IQR generally 
falling around 4%. Similarly, K, a species not 
associated with admissions in full-year analyses, 
had a significant excess risk of 4.0% (95% CI, 
0.3–7.7) during the cool season. 
Discussion 
Our analysis of hospital admissions for chil-
dren indicates that PM2.5 and several of its 
components have important effects on hospital 
admissions for respiratory diseases, especially 
acute bronchitis and pneumonia. Acute expo-
sure to total PM2.5 was associated with total 
respiratory hospital admissions for those < 19 
years and < 5 years of age. Children < 5 years 
of age were particularly sensitive to PM2.5 and 
several of its components including EC, OC, 
NO3, SO4, Fe, and Si. We observed excess 
risks of 3–7% for many of the respiratory out-
comes, based on species IQR. We observed 
similar risks during the cool season, where 
associations with K were also demonstrated. 
Figure 1. Association of PM2.5 species with total respiratory admissions for those 
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Figure 2. Association of PM2.5 species with total respiratory admissions during the 
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The associations demonstrated for total 
PM2.5 levels corroborate previous studies 
that observed effects of fine PM on respira-
tory hospitalizations in children (Barnett 
et al. 2005; Lin et al. 2002; van der Zee et al. 
1999). Earlier studies also found associations 
between PM < 10 µm in aerodynamic diam-
eter (PM10) and total respiratory, asthma, 
and pneumonia hospitalizations (Pope 1989; 
Tolbert et al. 2000). Despite the direct causes 
of pneumonia and other respiratory infec-
tions being biologic in nature, the effect of air 
pollution on the development of severe cases 
requiring hospitalization is especially plausible 
in children, because particulates likely hamper 
the ability of an already immature immune 
system to clear bacteria and other pathogens 
from the lung (Dietert et al. 2000). Other 
studies have also indicated that short-term 
incidences of respiratory disease may not be 
the only impact on children’s health. Lung 
development itself may be compromised, as 
PM2.5 and, more specifically, EC were among 
pollutants strongly associated with decreased 
lung function attainment in school children 
(Gauderman et al. 2004).
These studies of children also complement 
previous studies on elderly populations report-
ing associations between PM2.5 and PM10 
levels and hospitalizations for respiratory dis-
eases, including respiratory tract infections, 
chronic obstructive pulmonary disease, and 
pneumonia (Dominici et al. 2006; Zanobetti 
et al. 2000). 
Because data collection on the chemi-
cal components of PM2.5 has only recently 
begun, however, fewer studies are available 
on the effects related to specific species. 
Most of these studies link specific compo-
nents of PM2.5 to mortality. For example, 
in analyses of six California counties and of 
Phoenix, Arizona, acute exposure to several 
of these components, including EC, OC, Fe, 
Zn, and K, was associated with increases in 
daily counts of mortality (Mar et al. 2004; 
Ostro et al. 2007). In contrast, previous epi-
demiologic studies looking at fine particle 
constituents and morbidity have been sparse. 
Associations between OC and emergency 
department visits for pneumonia have been 
reported (Peel et al. 2005), as well as asthma 
attacks in children and exhaled nitric oxide, a 
biomarker for airway inflammation (Delfino 
et al. 2003, 2006; Peel et al. 2005; Sinclair 
and Tolsma 2004). A recent study of pre-
school-age children in the Czech Republic 
reported associations between bronchitis and 
both PM2.5 and polycyclic aromatic hydrocar-
bons (PAHs) (Hertz-Picciotto et al. 2007).
To date, studies focusing on NO3 and 
SO4 have been mixed in their findings 
(Schlesinger et al. 2006). We observed asso-
ciations between daily exposure to NO3 and 
respiratory disease for both those < 19 years 
and those < 5 years of age and more modest 
associations between SO4 and acute bronchi-
tis. NO3 constitute a significantly larger, and 
SO4 a smaller, share of PM2.5 in California 
than observed in most of the rest of the 
United States (Bell et al. 2007). However, 
because of lack of available data, NO3 have 
not been extensively examined in epidemio-
logic studies of air pollution. In one of the 
few previous studies examining the association 
between acute exposure to SO4 and respira-
tory morbidity in children, an association was 
observed for children with chronic respira-
tory symptoms between SO4 and both lower 
respiratory tract symptoms and decrements 
in lung function (van der Zee et al. 1999). 
In addition, Burnett et al. (1995) reported 
associations between SO4 and respiratory hos-
pital admissions for children < 15 years of age 
among hospitals in the province of Ontario, 
Canada, and Sarnat et al. (2008) found asso-
ciations between emergency department vis-
its for respiratory disease with SO4, but not 
with any other species, in an Atlanta-based 
study. Although motor vehicle fuel combus-
tion sources of NO3 are, of course, ubiqui-
tous throughout the state, there are only a 
few major sources of SO4 in California, 
because most state utilities do not use either 
coal or oil. These sources are found primarily 
in the Los Angeles Air Basin and are associ-
ated with the local port facilities. Major SO4 
sources include petroleum refining (both fuel 
combustion and industrial processes), heavy 
duty diesel trucks, and fuel combustion of 
ships and commercial boats (California Air 
Resources Board 2007).
We also found associations between hos-
pital admissions and several metals including 
Cu, Fe, and, to a lesser extent, Zn. Existing 
studies indicate that Fe is a marker for brake 
wear and is found in road dust and soil, and 
Cu and Zn may be generated from vehic-
ular-related sources including brake wear, 
emissions from lubrication oil, and tire wear 
(Schauer et al. 2006). Several human and ani-
mal studies have reported associations of fer-
ric iron and other metallic compounds with 
the generation of oxidative stress and pulmo-
nary inflammation (Ghio 2004; Pritchard 
et al. 1996), and another study in laboratory 
rats demonstrated that pulmonary Fe expo-
sure impaired both immune function and the 
ability to clear bacteria (Zelikoff et al. 2002). 
Burnett et al. (2000) reported associations 
between mortality and daily exposures to sev-
eral metals, including Zn, nickel, and Fe in 
their study of eight Canadian cities. In addi-
tion, Hirshon et al. (2008) found associations 
between ambient Zn and asthma urgent care 
visits and hospitalization among a cohort of 
individuals < 18 years of age. Intratracheal 
instillation studies in rodents demonstrated 
that pulmonary neutrophilic inflammation 
and protein leakage could be partially repro-
duced by zinc sulfate and copper sulfate, both 
major transition metals in the PM samples 
(Gottipolu et al. 2008; Kodavanti et al. 2002). 
Cu itself induced pulmonary inflammation, 
and in combination with Zn produced higher 
numbers of total lavageable cells and neutro-
phils than either treatment alone (Gottipolu 
et al. 2008). Our findings for Si are supported 
by evidence that crystalline silica is a well-
known occupational fibrosis hazard and can 
produce oxidative stress, lung inflammation, 
and cell death at relatively low exposures 
(Kaewamatawong et al. 2006). 
Although the above evidence presents the 
case that specific constituents cause direct 
effects, our study examines levels of PM2.5 
constituents under real-world conditions, and 
our observed effects for one constituent may 
be attributable to its correlation with other 
constituents from a similar generating source. 
Source apportionment was not performed 
in this current analysis; however, a study of 
source apportionment methods found that 
correctly selected single-species tracers can be 
almost as informative in identifying source 
contributions as more rigorous methods 
(Sarnat et al. 2008). 
EC, the tracer for diesel particulates used 
by Sarnat et al. (2008), is likely a reasonable 
marker for diesel exhaust in this study as well. 
Because there are few other sources of primary 
emissions of carbonaceous material such as 
coal and fuel oil combustion in California, 
approximately 80% or more of the EC is 
derived from diesel exhaust (Schauer and Cass 
2000). Existing toxicologic and human clin-
ical studies (Salvi et al. 1999) indicate that 
diesel exhaust particles induce both pulmo-
nary inflammation and cell damage, including 
death of alveolar macrophages, through the 
generation of reactive oxygen species (Hiura 
et al. 2000; Mar et al. 2000; Nel et al. 2001). 
Alveolar macrophage death may lessen defense 
against pulmonary pathogens. Atopic indi-
viduals challenged intranasally with diesel 
exhaust particles and an allergen exhibited 
increased antigen-specific immunoglobulin E, 
cytokine, and chemokine levels and increased 
mast cell degranulation, indicating enhanced 
allergic inflammation, the principal hallmark 
of asthma (Diaz-Sanchez et al. 1997, 2000; 
Nel et al. 1998). So in relation to the EC asso-
ciations observed in our study, EC could be 
serving as a surrogate for the larger category 
of diesel exhaust particles, which, in addition 
to EC, can include trace metals or adherent 
organic hydrocarbons such as PAHs, any or all 
of which could be acting to cause physiologic 
effects (Li et al. 2003). 
Other studies apportioning ambient PM2.5 
levels to sources suggest that acute exposure to 
particles from motor vehicle exhaust, fossil 
fuel combustion, and vegetative burning—all Fine particle components and hospitalization
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sources marked by emissions of EC and OC 
(Sarnat et al. 2008)—is associated with both 
respiratory morbidity (Andersen et al. 2007) 
and daily mortality (Laden et al. 2000; Mar 
et al. 2000). 
Our findings suggesting effects for metals, 
NO3, SO4, EC, and OC implicate man-made 
combustion sources (i.e., emissions from 
motor vehicle and industrial fuel combus-
tion, refineries, and industrial processes) and 
related processes (i.e., brake and tire wear) 
as significant producers of bioactive fine par-
ticulate. K, generally regarded as a marker 
for wood and biomass burning (Khalil and 
Rasmussen 2003; Laden et al. 2000; Sarnat 
et al. 2008), was not consistently related to 
respiratory admissions in our full-year analy-
ses. However, cold season–specific K levels 
were significantly associated with respiratory 
admissions, implying that fine particles from 
wood smoke may also contribute to respi-
ratory morbidity, as has been suggested in 
previous research (Naeher et al. 2007). Si is 
generally regarded as a good tracer for crustal 
or soil particles (Laden et al. 2000; Marcazzan 
et al. 2001), and the significant associations 
we found between Si and respiratory admis-
sions suggest that crustal particulates can also 
affect respiratory health. 
We found that for many of the respira-
tory outcomes, stronger associations tended 
to occur with a 1- to 3-day lag of the species. 
Although there is little to justify an appropri-
ate lag structure a priori for the vast majority 
of PM2.5 constituents, it is of note that Peel 
et al. (2005) also found that lags of several 
days were significant for respiratory ER visits 
for children. Additional support for longer 
lags for respiratory disease outcomes is pro-
vided by two multicity studies, where hospital 
admissions for pneumonia were more strongly 
associated with lags of 2 days or more (Braga 
et al. 2001; Zeka et al. 2005). In our analysis, 
as in the others cited, it is unclear whether the 
longer lag associations are attributable to bio-
logic mechanisms or simply to stochastic vari-
ability. However, it is plausible that a latency 
of several days may occur between exposure 
and exacerbation of infection because of 
inflammation and immune suppression. In 
addition, there may be a delay between expo-
sure and actual day of hospital admission, as 
opposed to an emergency department visit. 
It is important to note the limitations of 
our study. First, spatial coverage of the moni-
tors is limited for several of the counties. This 
is likely to introduce random measurement 
error into the analysis and the potential for 
downwardly biasing the effect estimates. In 
addition, differences in measurement tech-
niques or spatial heterogeneity among con-
stituents could introduce different levels of 
measurement error. Second, this study shares 
a shortcoming with other particulate studies 
relying on nondaily data. Because readings 
are taken every 3 days, comparisons of effect 
between lags are less direct than they would 
be with daily data. For this analysis, a same-
day lag analysis compares measurements with 
hospitalizations that occurred on days when 
readings were taken. A 1-day lag analysis looks 
at the association between those same readings 
and all hospitalizations taking place 1 day after 
a measurement day, or what is in essence a 
different risk set. This introduces a greater pos-
sibility of chance differences in comparisons 
between different lags. Third, given the num-
bers of pollutants and end points examined 
and the relatively low number of observations, 
it is possible that some of the results may have 
occurred by chance or that the power to detect 
effects is limited. This likelihood is dimin-
ished somewhat by using a multicounty study 
design, which minimizes the likelihood that 
an unusual chance finding observed in one 
geographic area would heavily influence our 
conclusions. Also, in view of previous stud-
ies, our results seem quite plausible in terms 
of both the end points and the components 
for which associations were observed. Finally, 
associations for a given component may reflect 
its own toxicity or the toxicity of a corre-
lated, measured or unmeasured, co-pollutant. 
Therefore, some caution is justified in attribut-
ing effects to any single component. 
Our findings indicate that hospital admis-
sions for childhood respiratory disease, espe-
cially pneumonia, are associated with exposure 
to PM2.5 and several of its components. 
Because these components and their related 
sources, including diesel exhaust, motor vehi-
cle emissions, biomass burning, and other fuel 
combustion processes, are ubiquitous in the 
urban environment, small reductions in their 
concentrations could have a noticeable effect 
on childhood respiratory morbidity. 
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